作者:
Quynh Lan,Nguyen [1]
;
Katharina,Hees [2]
;
Sabina,Hernandez Penna [1]
;
Franz,König [3]
;
Martin,Posch [4]
;
Marta,Bofill Roig [4]
;
Elias Laurin,Meyer [4]
;
Michaela Maria,Freitag [4]
;
Tom,Parke [5]
;
Maximilian,Otte [6]
;
Hans-Peter,Dauben [7]
;
Tobias,Mielke [8]
;
Cecile,Spiertz [8]
;
Peter,Mesenbrink [9]
;
Madhavi,Gidh-Jain [10]
;
Suzanne,Pierre [11]
;
Salvatore,Morello [12]
;
Benjamin,Hofner [12]
作者单位:
Section Data Science and Methods, Paul-Ehrlich-Institut, Langen, Germany.
[1]
Department of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
[2]
Novartis Pharma AG, Basel, Switzerland.
[3]
Institute for Medical Statistics, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
[4]
Berry Consultants, Vienna, Austria.
[5]
Charité - Universitätsmedizin Berlin, Berlin, Germany.
[6]
Berry Consultants, Abingdon, UK.
[7]
Euroscan, Cologne, Germany.
[8]
Statistics and Decision Sciences, Janssen-Cilag GmbH, Neuss, Germany.
[9]
Janssen Biologics, Leiden, The Netherlands.
[10]
Analytics, Development, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
[11]
Sanofi, Gentilly, France.
[12]
Janssen R&D, Springhouse, PA, USA.
[13]
DOI
10.1002/cpt.3244
PMID
38529786
发布时间
2024-06-16